Why Amgen’s positive biosimilar news isn’t as good as it seems
July 13, 2016 at 12:39 PM EDT
FDA committee’s unanimous vote belies the complexity of getting these new drugs to market.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.